XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2026
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

 

Basis of Consolidation and Presentation

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: Rainwater Acquisition Corp. (f.k.a Merger Sub 1) and RET. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Certain disclosures normally included in financial statements have been condensed or omitted from these unaudited condensed consolidated financial statements as they are not required for interim financial statements under GAAP and the rules of the SEC. Accordingly, these unaudited condensed consolidated financial statements do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation of the financial position, operating results and cash flows for the periods presented have been included. Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026 or any future period.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as of December 31, 2025, as filed with the SEC on April 15, 2026, which contains the Company’s audited consolidated financial statements and notes thereto.

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are stated at fair value and may include money market funds, U.S. Treasury and U.S. government-sponsored agency securities, corporate debt, commercial paper, and certificates of deposit. The Company had no cash equivalents as of September 30, 2026 and December 31, 2025.

 

Deferred Financing Costs

 

The Company capitalizes costs directly associated with equity financings until such financings are consummated, at which time such costs are recorded in additional paid-in capital against the gross proceeds of the equity financings. Costs associated with the prospectus supplement to the shelf registration statement on Form S-3 filed for the ATM program (as defined in Note 4) with the SEC are allocated to additional paid-in capital on a pro rata basis as shares are issued under the program. Any remaining unallocated costs continue to be deferred and will be charged against additional paid-in capital upon future issuances under the program or expensed immediately should the Company terminate the ATM program prior to raising the full amount.

 

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying consolidated balance sheets, either because of the short-term nature of the instruments or because the instruments are recognized at fair value.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

  ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

  ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Derivative Financial Instruments

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The assessment considers whether the financial instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the financial instruments meet all of the requirements for equity classification under ASC 815, including whether the financial instruments are indexed to the Company’s own ordinary shares, among other conditions for equity classification.

 

Foreign Currency Translation and Transactions

 

The U.S. dollar is the Company’s functional currency. Transactions denominated in currency other than the Company’s functional currency are recorded at the rates of exchange prevailing on the dates of the transactions. At each balance sheet date, monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency at the rates prevailing at the balance sheet date. The remeasurement of these transactions is included in the Company’s consolidated statements of operations within the general and administrative expenses.

 

During the three and nine months ended September 30, 2026 and 2025, the Company incurred certain costs related to technical operations and research and development activities denominated in Australian dollars. The amount of these foreign currency payments was translated into U.S. dollars.

 

Equipment and Construction In-Process Equipment

 

The Company capitalizes its cost to build its rainfall ionization equipment (the “Equipment”), including materials and allocated labor costs directly attributable to the construction of the Equipment. Upon the installation of the Equipment, the Company transfers its capitalized cost from Construction in-process Equipment to Equipment. Equipment that has been completed but has not yet been installed or otherwise placed into service remains within Construction in-process Equipment and is not depreciated until transferred into Equipment and placed into service. Construction in-process Equipment includes costs for units under construction or in transit prior to installation.

 

In July 2024, the Company completed its building process for its two initial units. In January 2026, the Company completed building a total of 10 additional units.

 

Depreciation begins when the equipment is placed into service and is recorded on a straight-line basis over the estimated useful life of the assets, which the Company currently estimates to be 10 years. At the time of retirement or other disposition of the Equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting loss, if any, will be reflected in operations.

 

In November 2025, the first two systems were placed into service and moved from Construction in-process Equipment into Equipment. During the three and nine months ended September 30, 2026, the Company recorded approximately $10,000 and $31,000 of depreciation expense related to those units in the accompanying unaudited condensed consolidated statements of operations, respectively. The remaining 10 units were not placed in service and remained included in Construction in-process Equipment as of September 30, 2026 and December 31, 2025 in the accompanying unaudited condensed consolidated balance sheets.

 

Field operations costs represent expenses incurred in connection with the installation, operation, and maintenance of the Company’s AEI systems, including pilot installations and evaluation projects. These costs are expensed as incurred and primarily consist of labor, travel, site preparation, shipping and related operational expenses associated with system deployment and testing. During the three and nine months ended September 30, 2026, the Company received refunds of previously paid import tariffs totaling approximately $88,000, which were recorded as a reduction of field operations costs in the accompanying unaudited condensed consolidated statements of operations. As the Company is currently in an early stage of commercial deployment, certain installation activities may occur prior to the execution of revenue-generating customer agreements.

 

Equipment, including construction in-process Equipment, as of September 30, 2026 and December 31, 2025 was comprised of the following:

 

    September 30,
2026
    December 31,
2025
 
Equipment:            
Rainfall ionization equipment and systems, in-process   $ 997,289     $ 987,805  
Rainfall ionization equipment and systems, completed     414,034       414,034  
Less: Rainfall ionization equipment and systems, accumulated depreciation     (37,954 )     (6,901 )
Net rainfall ionization equipment and systems, completed     376,080       407,133  
Total   $

1,373,369

    $ 1,394,938  

 

Intangible Assets

 

Recognized intangible assets have finite lives and include acquired licenses for market-ready technology and designs of weather modification and rainfall ionization equipment. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses.

 

Intangible assets with finite lives are amortized using the straight-line method over the estimated useful economic life. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the statements of operations and in the expense category that is consistent with the function of the intangible assets.

  

Intangible assets with finite lives are tested for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. These conditions may include a change in the extent or manner in which the asset is being used or a change in future operations. The Company assesses the recoverability of the carrying amount by preparing estimates of future revenue, margins, and cash flows. If the sum of expected future cash flows (undiscounted and without interest charges) is less than the carrying amount, an impairment loss is recognized. The impairment loss recognized is the amount by which the carrying amount exceeds the fair value of the asset. Fair value of these assets may be determined by a variety of methodologies, including discounted cash flow models. No impairment was recorded for the three and nine months ended September 30, 2026 and 2025.

 

As of September 30, 2026 and December 31, 2025, the Company did not have any intangible assets with indefinite useful lives.

 

    Weighted
Average
  Carrying Value  
    Useful Life
(Years)
  September 30,
2026
    December 31,
2025
 
Intangible assets:                
Licensed technology for weather modification   10   $ 33,000     $ 33,000  
Purchased intellectual property for rainfall ionization equipment   10     83,750       83,750  
Less:                    
Accumulated amortization         (44,754 )     (35,998 )
Total intangible assets, net       $ 71,996     $ 80,752  

 

Research and Development Expenses

 

Research and development costs are expensed as incurred. Research and development expenses consist of expenditures incurred in the discovery and development of new products, processes or services and the improvement of existing products, processes or services and the cost of conducting trials.

 

Research and Development Tax Credits

 

During the three months ended September 30, 2026, the Company recognized approximately $87,000 in federal research and development tax credits related to qualifying research activities following the completion of an assessment of its eligibility for such credits. The credits are available to offset future employer payroll tax liabilities and were recorded as other receivables and a reduction to general and administrative expenses in the accompanying unaudited condensed consolidated financial statements. As of September 30, 2026, the credits had not been utilized.

 

Leases

 

The Company follows the guidance of FASB ASC Topic 842, “Leases,” which requires an entity to recognize a right-of-use (“ROU”) asset and a lease liability for virtually all leases. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be.

 

The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less. The Company recognizes the lease payments associated with its short-term land leases as an expense on a straight-line basis over the lease term.

 

Stock-based Compensation

 

The Company’s policy is to account for stock-based compensation expense in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to performance conditions, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed consolidated financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2026 and December 31, 2025. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major tax authorities since inception.

 

Net Loss Per Common Share

 

Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the periods. Diluted net loss per common share is computed by adjusting basic net loss per common share for the effect of all potentially dilutive shares of common stock, including restricted stock awards (“RSAs”), warrants, and stock options, using the applicable methods under ASC 260. The dilutive effect of stock options, warrants, and applicable share-based awards is determined using the treasury stock method. Potential common shares are included in the computation of diluted net loss per common share only when their effect is dilutive and are excluded when their effect would be anti-dilutive. Accordingly, basic and diluted net income (loss) per common share are the same when all potential common shares are anti-dilutive.

 

As of September 30, 2026 and 2025, the Company had 5,000,000 warrants and 2,150,838 stock options outstanding in each period, and 301,160 and 602,320 unvested RSAs, respectively, that were excluded from the computation of diluted net loss per common share because their inclusion would have been anti-dilutive.

 

The net loss per common share presented in the consolidated statements of operations is based on the following for the three and nine months ended September 30, 2026 and 2025:

 

    For the three months ended September 30,  
    2026     2025  
    Class A
common stock
    Class B
common stock
    Class A
common stock
    Class B
common stock
 
Basic and diluted net loss per common share:                        
Numerator:                        
Allocation of net loss   $ (2,594,044 )   $ (13,793 )   $ (2,183,435 )   $ (16,749 )
                                 
Denominator:                                
Basic and diluted weighted average share outstanding     10,861,503       57,752       7,528,761       57,752  
Basic and diluted net loss per common share   $ (0.24 )   $ (0.24 )   $ (0.29 )   $ (0.29 )

 

    For the nine months ended September 30,  
    2026     2025  
    Class A
common stock
    Class B
common stock
    Class A
common stock
    Class B
common stock
 
Basic and diluted net loss per common share:                        
Numerator:                        
Allocation of net loss   $ (7,665,839 )   $ (48,883 )   $ (4,600,112 )   $ (35,287 )
                                 
Denominator:                                
Basic and diluted weighted average share outstanding     9,056,591       57,752       7,528,761       57,752  
                                 
Basic and diluted net loss per common share   $ (0.85 )   $ (0.85 )   $ (0.61 )   $ (0.61 )

 

Recent Accounting Pronouncements

 

Issued in November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40), requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses and the Company’s definition of selling expenses. In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted, and the guidance may be applied prospectively or retrospectively. The Company does not plan to adopt this guidance early. The Company is currently evaluating the provisions its impact on the Company’s unaudited condensed consolidated financial statements.

 

Management reviews the carrying value of equipment and construction in-process equipment for impairment whenever events and circumstances indicate that the carrying value of equipment and construction in-process equipment may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of equipment and construction in-process equipment. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property and equipment are used, and the effects of obsolescence, demand, competition, and other economic factors.